ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Technical Specialist, Engineering and Facilities at Beam Therapeutics - ApplyBlast

Senior Technical Specialist, Engineering and Facilities

Beam Therapeutics

3 months ago

4.1 on Glassdoor

Durham, North Carolina, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Senior Technical Specialist, Engineering and Facilities at Beam Therapeutics will serve as the primary technical and engineering documentation resource across capital projects, process engineering, automation & controls, and facilities & maintenance. The role focuses on authoring and reviewing complex engineering documents, leading lifecycle quality events, and ensuring regulatory compliance to support commercial operational readiness.

Responsibilities

Author and review complex engineering documentation
Lead root cause analysis for facility and equipment issues
Initiate and drive engineering deviations, CAPAs, and change controls
Facilitate quality risk assessments and FMEAs
Maintain audit‑ready engineering lifecycle documentation

Skills

Qualifications

B.S. in EngineeringB.S. in Biochemistry

About Beam Therapeutics

beamtx.com

Headquarters

Cambridge, Massachusetts, United States

Company Size

501-1000 employees

Founded

2017

View Profile

Beam Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, pioneering precision genetic medicines using its proprietary base editing platform to make precise single‑base DNA changes without creating double‑strand breaks. The company advances both in vivo and ex vivo programs across hematology, rare genetic diseases, and oncology, moving several candidates toward clinical development. Beam combines engineered editors, delivery technologies, and extensive safety profiling to create durable, potentially one‑time treatments and partners with academic and industry collaborators to accelerate translation.